The filing is a routine insider sale for tax withholding upon option exercise. The small size relative to market cap suggests no material signal. Monitor for any subsequent Form 4 filings to confirm the actual sale.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $104.01entry
- T+1 · 6d ago +1.73%α +0.41% · $105.81
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Donald E. Bobo Jr., an officer of Edwards Lifesciences, filed a Form 144 notice of intent to sell 48,900 shares of common stock, with an approximate market value of $5.04 million based on the filing. The sale is related to a cashless exercise of employee stock options and is scheduled for November 9, 2026. The filing signals a planned insider sale, but the amount is relatively small relative to the company's $57.9B market cap.
Key Facts
- Insider: Donald E. Bobo Jr., an officer of Edwards Lifesciences
- Shares to be sold: 48,900 shares of common stock
- Approximate value: $5,039,313 (based on filing)
- Sale date: November 9, 2026
- Nature: Broker payment for cashless exercise of employee stock options
- Company market cap: $57.9B
Financial Impact
Sale of 48,900 shares valued at approximately $5.04 million, representing less than 0.01% of the company's market cap.
Risk Factors
- Insider sale could be perceived negatively if it precedes a negative catalyst, but no such catalyst is indicated in the filing.
- The sale is part of a cashless exercise, which is a standard practice for option exercises and not necessarily a bearish signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-001149 |
| Document: 0001921094-26-001149-index.html | 0001921094-26-001149 |
| Document: 0001921094-26-001149.txt | 0001921094-26-001149 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers